A study of the efficacy, safety and quality of life in Patients with chronic idiopathic urticaria dosed with AERIUS tablets (5mg,10mg,or20mg once daily)
Laufzeit: 01.01.2007 - 31.12.2008
Kurzfassung
The study will consist of a Screening Visit, followed by a 7 - day entry period ( Baseline Week - UAS baseline assessment), followed by a 28-day Dose-Respones Treatment period, a follow up telephone call will be made 2 weeks afer the final visit
